InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: Wordonthastreet post# 32265

Sunday, 02/04/2018 11:59:01 AM

Sunday, February 04, 2018 11:59:01 AM

Post# of 50154
I hear you Word.
I'm also invested in a few Phase 3 biotechs. One specifically is loooking for MONO treatment for AIDS instead of the HAART combinations of drugs, and the PPS is floating between 50-55 cents lately. Nothing on the market, no income, and only phase 3 trials going on. Speculation is results by end of quarter one and PPS could jump to 3-5 dollars per share!
I really see no difference in tactics here at DCTH other than loss of investor faith due to the toxic financing that had to take place to regain control of the company's patents. In due time, investor faith will be restored, and I see this walking back towards the .10-.25 range. As long as the company doesn't do anymore toxic financing deals and puts out clear guidance on future direction. This small company could prove to be a goldmine if ran the right way!
Best of luck my friend!
IMHO

In My Own Personal Opinion Of Course!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News